Published in J Control Release on June 28, 2014
Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer (2016) 0.99
Nanoparticle-Based and Bioengineered Probes and Sensors to Detect Physiological and Pathological Biomarkers in Neural Cells. Front Neurosci (2015) 0.81
Biological interactions of carbon-based nanomaterials: From coronation to degradation. Nanomedicine (2015) 0.81
Zwitterionic amphiphile coated magnetofluorescent nanoparticles - synthesis, characterization and tumor cell targeting. J Mater Chem B Mater Biol Med (2015) 0.80
Elimination of the biphasic pharmacodynamics of 15d-PGJ2 by controlling its release from a nanoemulsion. Int J Nanomedicine (2016) 0.78
Selection of potential iron oxide nanoparticles for breast cancer treatment based on in vitro cytotoxicity and cellular uptake. Int J Nanomedicine (2017) 0.77
Ligand-based targeted therapy: a novel strategy for hepatocellular carcinoma. Int J Nanomedicine (2016) 0.77
Effects of the Microparticle Shape on Cellular Uptake. Mol Pharm (2016) 0.77
Dressing up Nanoparticles: A Membrane Wrap to Induce Formation of the Virological Synapse. ACS Nano (2015) 0.77
Photothermal and photodynamic activity of polymeric nanoparticles based on α-tocopheryl succinate-RAFT block copolymers conjugated to IR-780. Acta Biomater (2017) 0.76
Novel stable cytokine delivery system in physiological pH solution: chitosan oligosaccharide/heparin nanoparticles. Int J Nanomedicine (2015) 0.76
Fluorescence and electron microscopy to visualize the intracellular fate of nanoparticles for drug delivery. Eur J Histochem (2016) 0.76
Nanoparticle-based targeted gene therapy for lung cancer. Am J Cancer Res (2016) 0.76
Endocytotic potential governs magnetic particle loading in dividing neural cells: studying modes of particle inheritance. Nanomedicine (Lond) (2016) 0.75
Plasmonic labeling of subcellular compartments in cancer cells: multiplexing with fine-tuned gold and silver nanoshells. Chem Sci (2017) 0.75
Biocompatible Fluorescent Core-Shell Nanoconjugates Based on Chitosan/Bi2S3 Quantum Dots. Nanoscale Res Lett (2016) 0.75
Leveraging Colloidal Aggregation for Drug-Rich Nanoparticle Formulations. Mol Pharm (2017) 0.75
Multifunctional decoration of alpha-tocopheryl succinate-based NP for cancer treatment: effect of TPP and LTVSPWY peptide. J Mater Sci Mater Med (2017) 0.75
Overviews on the cellular uptake mechanism of polysaccharide colloidal nanoparticles. J Cell Mol Med (2017) 0.75
Cobalt nanoparticles induce lung injury, DNA damage and mutations in mice. Part Fibre Toxicol (2017) 0.75
pH-Responsive Mesoporous Silica and Carbon Nanoparticles for Drug Delivery. Bioengineering (Basel) (2017) 0.75
Covalent, Non-Covalent, Encapsulated Nanodrug Regulate the Fate of Intra- and Extracellular Trafficking: Impact on Cancer and Normal Cells. Sci Rep (2017) 0.75
Triptolide and celastrol loaded silk fibroin nanoparticles show synergistic effect against human pancreatic cancer cells. Nanoscale (2017) 0.75
pH-Sensitive O6-Benzylguanosine Polymer Modified Magnetic Nanoparticles for Treatment of Glioblastomas. Bioconjug Chem (2016) 0.75
Co-delivery of polyinosinic:polycytidylic acid and flagellin by poly(lactic-co-glycolic acid) MPs synergistically enhances immune response elicited by intranasally delivered hepatitis B surface antigen. Int J Nanomedicine (2017) 0.75
A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A (1995) 18.16
BAR domains as sensors of membrane curvature: the amphiphysin BAR structure. Science (2003) 12.60
Mitochondrial diseases in man and mouse. Science (1999) 11.67
Endocytosis and the recycling of plasma membrane. J Cell Biol (1983) 10.24
Mechanisms of endocytosis. Annu Rev Biochem (2009) 10.07
Mechanisms of phagocytosis in macrophages. Annu Rev Immunol (1999) 9.66
Curvature of clathrin-coated pits driven by epsin. Nature (2002) 8.03
Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature (1988) 7.65
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm (2005) 7.53
Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov (2010) 7.48
The effect of particle design on cellular internalization pathways. Proc Natl Acad Sci U S A (2008) 7.06
Angiogenesis. Annu Rev Med (2006) 6.94
The multiple faces of caveolae. Nat Rev Mol Cell Biol (2007) 6.85
Shape effects of filaments versus spherical particles in flow and drug delivery. Nat Nanotechnol (2007) 6.85
Role of target geometry in phagocytosis. Proc Natl Acad Sci U S A (2006) 6.62
Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell (1996) 6.52
Molecular mechanism and physiological functions of clathrin-mediated endocytosis. Nat Rev Mol Cell Biol (2011) 6.32
Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs. Science (2010) 6.01
Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile. Sci Transl Med (2012) 5.92
Pathways and mechanisms of endocytic recycling. Nat Rev Mol Cell Biol (2009) 5.60
Endosome maturation. EMBO J (2011) 5.22
Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging. Proc Natl Acad Sci U S A (2007) 5.17
ER stress and diseases. FEBS J (2007) 5.03
ADP-ribosylation factor 6 regulates a novel plasma membrane recycling pathway. J Cell Biol (1997) 4.76
Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells. Nature (2013) 4.71
Clathrin. Annu Rev Biochem (2000) 4.20
Targeting mitochondria for cancer therapy. Nat Rev Drug Discov (2010) 4.07
Primary structure of human transferrin receptor deduced from the mRNA sequence. Nature (1984) 4.04
The golden age: gold nanoparticles for biomedicine. Chem Soc Rev (2011) 3.89
Virus entry by macropinocytosis. Nat Cell Biol (2009) 3.87
Crossing the nuclear envelope: hierarchical regulation of nucleocytoplasmic transport. Science (2007) 3.86
Structure and analysis of FCHo2 F-BAR domain: a dimerizing and membrane recruitment module that effects membrane curvature. Structure (2007) 3.67
EGF receptor ligands. Exp Cell Res (2003) 3.60
Distinct endocytotic pathways in epidermal growth factor-stimulated human carcinoma A431 cells. J Cell Biol (1989) 3.58
Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung. Nat Biotechnol (2007) 3.54
The structural era of endocytosis. Science (1999) 3.53
Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. Adv Drug Deliv Rev (2013) 3.44
Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat Nanotechnol (2013) 3.39
The ErbB receptors and their role in cancer progression. Exp Cell Res (2003) 3.37
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem Soc Rev (2012) 3.34
Nucleotide-dependent conformational changes in dynamin: evidence for a mechanochemical molecular spring. Nat Cell Biol (1999) 3.28
Interleukin 2 receptors and detergent-resistant membrane domains define a clathrin-independent endocytic pathway. Mol Cell (2001) 3.25
Endocytosis of nanomedicines. J Control Release (2010) 3.23
Dysregulated pH: a perfect storm for cancer progression. Nat Rev Cancer (2011) 3.10
To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release (2010) 3.06
Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. Acc Chem Res (2007) 3.03
Caveolae as plasma membrane sensors, protectors and organizers. Nat Rev Mol Cell Biol (2013) 2.98
Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. Cancer Res (2013) 2.98
Nanomedicine. N Engl J Med (2010) 2.97
Stimulation-dependent recycling of integrin beta1 regulated by ARF6 and Rab11. Traffic (2004) 2.91
The role of alphav integrins during angiogenesis: insights into potential mechanisms of action and clinical development. J Clin Invest (1999) 2.88
Macropinosome maturation and fusion with tubular lysosomes in macrophages. J Cell Biol (1993) 2.86
Biosynthesis of the human transferrin receptor in cultured cells. J Biol Chem (1981) 2.83
The role of disturbed pH dynamics and the Na+/H+ exchanger in metastasis. Nat Rev Cancer (2005) 2.82
Kinase-regulated quantal assemblies and kiss-and-run recycling of caveolae. Nature (2005) 2.75
Integrating molecular and network biology to decode endocytosis. Nature (2007) 2.73
Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles. Proc Natl Acad Sci U S A (2009) 2.72
Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects. Bioconjug Chem (2010) 2.72
Defining macropinocytosis. Traffic (2009) 2.56
EGFR signaling and drug discovery. Oncology (2010) 2.53
Clathrin assembly lymphoid myeloid leukemia (CALM) protein: localization in endocytic-coated pits, interactions with clathrin, and the impact of overexpression on clathrin-mediated traffic. Mol Biol Cell (1999) 2.49
The first five seconds in the life of a clathrin-coated pit. Cell (2012) 2.48
Interfering with pH regulation in tumours as a therapeutic strategy. Nat Rev Drug Discov (2011) 2.45
Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: a randomised crossover trial in advanced colorectal cancer. Eur J Cancer (2002) 2.34
Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury. FASEB J (2005) 2.33
Paul Ehrlich's magic bullet concept: 100 years of progress. Nat Rev Cancer (2008) 2.21
Delivery of bioactive molecules to mitochondria in vivo. Proc Natl Acad Sci U S A (2003) 2.12
Endoplasmic reticulum stress as a therapeutic target in cardiovascular disease. Circ Res (2010) 2.12
Design of polymeric nanoparticles for biomedical delivery applications. Chem Soc Rev (2012) 2.11
Transformation-associated changes in sphingolipid metabolism sensitize cells to lysosomal cell death induced by inhibitors of acid sphingomyelinase. Cancer Cell (2013) 2.09
Subcellular targeting strategies for drug design and delivery. Nat Rev Drug Discov (2010) 2.04
The transferrin receptor: role in health and disease. Int J Biochem Cell Biol (1999) 2.02
Autism and brain development. Cell (2008) 2.01
Role of the Sec61 translocon in EGF receptor trafficking to the nucleus and gene expression. Mol Biol Cell (2007) 1.99
Folate-targeted therapeutic and imaging agents for cancer. Curr Opin Chem Biol (2009) 1.97
Shape induced inhibition of phagocytosis of polymer particles. Pharm Res (2008) 1.91
Radiolabeled cyclic RGD peptides as integrin alpha(v)beta(3)-targeted radiotracers: maximizing binding affinity via bivalency. Bioconjug Chem (2009) 1.88
Lysosomes revisited. Eur J Biochem (1983) 1.86
Information processing during phagocytosis. Nat Rev Immunol (2012) 1.84
The endocytic activity of dendritic cells. J Exp Med (1995) 1.82
The uptake and intracellular fate of PLGA nanoparticles in epithelial cells. Biomaterials (2009) 1.82
Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles. J Control Release (2009) 1.81
Christianson syndrome protein NHE6 modulates TrkB endosomal signaling required for neuronal circuit development. Neuron (2013) 1.79
Discovery of new cargo proteins that enter cells through clathrin-independent endocytosis. Traffic (2009) 1.78
Professional and non-professional phagocytes: an introduction. Trends Cell Biol (1995) 1.78
Caveolae: mining little caves for new cancer targets. Nat Rev Cancer (2003) 1.76
Combinatorial drug design targeting multiple cancer signaling networks controlled by mitochondrial Hsp90. J Clin Invest (2009) 1.72
Large unilamellar liposomes with low uptake into the reticuloendothelial system. FEBS Lett (1987) 1.71
The homodimer of prostate-specific membrane antigen is a functional target for cancer therapy. Proc Natl Acad Sci U S A (2003) 1.71
Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation. Acc Chem Res (2011) 1.71
Targeting lipophilic cations to mitochondria. Biochim Biophys Acta (2008) 1.70
High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression. J Biol Chem (2005) 1.67
Mitochondria-targeted small molecule therapeutics and probes. Antioxid Redox Signal (2011) 1.66
Rabies virus receptors. J Neurovirol (2005) 1.65
Zwitterionic hydrogels implanted in mice resist the foreign-body reaction. Nat Biotechnol (2013) 1.65
Targeting of nanoparticles to the clathrin-mediated endocytic pathway. Biochem Biophys Res Commun (2006) 1.64
Macropinocytosis: regulated coordination of endocytic and exocytic membrane traffic events. J Cell Sci (2006) 1.64
Integrins: molecular targets in cancer therapy. Curr Oncol Rep (2006) 1.63
Folate receptor-targeted immunotherapy of cancer: mechanism and therapeutic potential. Adv Drug Deliv Rev (2004) 1.59